Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Itron (ITRI) Change in Receivables: 2009-2025

Historic Change in Receivables for Itron (ITRI) over the last 16 years, with Sep 2025 value amounting to $30.9 million.

  • Itron's Change in Receivables rose 75.54% to $30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.1 million, marking a year-over-year increase of 134.56%. This contributed to the annual value of $49.1 million for FY2024, which is 152.07% up from last year.
  • Itron's Change in Receivables amounted to $30.9 million in Q3 2025, which was up 349.83% from -$12.4 million recorded in Q2 2025.
  • Itron's Change in Receivables' 5-year high stood at $36.8 million during Q1 2024, with a 5-year trough of -$37.7 million in Q2 2022.
  • Over the past 3 years, Itron's median Change in Receivables value was $12.2 million (recorded in 2023), while the average stood at $7.3 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first tumbled by 354.48% in 2023, then skyrocketed by 458.93% in 2024.
  • Itron's Change in Receivables (Quarterly) stood at -$19.6 million in 2021, then surged by 136.73% to $7.2 million in 2022, then slumped by 354.48% to -$18.3 million in 2023, then surged by 197.99% to $18.0 million in 2024, then skyrocketed by 75.54% to $30.9 million in 2025.
  • Its Change in Receivables stands at $30.9 million for Q3 2025, versus -$12.4 million for Q2 2025 and -$6.4 million for Q1 2025.